Mankind Pharma's credit ratings withdrawn by CARE Ratings

Mankind Pharma (BSE: MANKIND) announced that Care Ratings Limited ("CARE") has withdrawn its credit ratings on the company’s multiple debt instruments, including working capital limits, effective March 25, 2025. According to the company's statement, this action was taken at the request of Mankind Pharma. The ratings assigned by CARE are available on Mankind Pharma's website. Despite this withdrawal, Mankind Pharma clarifies that its instruments continue to be rated by other existing credit rating agencies. The company notes that its existing credit rating for CRISIL and ICRA is AA+ for term loan and A1+ for Commercial Paper. This information is for investors and the records.